补阳还五汤加减联合脑-肢协同调控治疗卒中后肢体功能障碍临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R743.3;R277.7

基金项目:

河南省医学科技攻关计划项目(2018020808)


Clinical Study on Modified Buyang Huanwu Decoction Combined with Brain-Limb Coordinated Regulation for Post-stroke Limb Dysfunction
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察补阳还五汤加减联合脑-肢协同调控治疗脑卒中后肢体功能障碍的疗效。方法:选取 96 例卒中后肢体功能障碍患者为研究对象,按随机数字表法分为对照组及观察组各48 例。对照组采取常规治 疗加脑-肢协同调控,观察组在对照组基础上采用补阳还五汤加减治疗。比较2 组临床疗效,比较2 组治疗前 后中医证候积分、血清指标[C-反应蛋白(CRP)、同型半胱氨酸(Hcy) ]、血流变指标[纤维蛋白原(Fib)、血浆 黏度、红细胞比容(HCT) ]、Fugl-Meyer 运动功能评分量表(FMA)、Berg 平衡量表(BBS)、功能性步行量 表(FAC) 评分的变化。结果:治疗4 周后,观察组临床疗效总有效率为95.83%,对照组为83.33%,2 组比 较,差异有统计学意义(P<0.05)。治疗后,2 组中医证候各积分均较治疗前下降(P<0.05),观察组中医证候 各积分均低于对照组(P<0.05)。治疗后,2 组CRP、Hcy 指标值均较治疗前下降(P<0.05),观察组上述2 项 指标值均低于对照组(P<0.05)。治疗4 周后,2 组Fib、血浆黏度、HCT 指标值均较治疗前下降(P<0.05), 观察组上述3 项指标值均低于对照组(P<0.05)。治疗4 周后,2 组FMA、BBS、FAC 评分均较治疗前升 高(P<0.05),观察组评分均高于对照组(P<0.05)。结论:补阳还五汤加减联合脑-肢协同调控治疗卒中后肢 体功能障碍能提升临床疗效,改善肌力、肌张力下降等症状,减轻炎症,促进肢体运动能力的恢复。

    Abstract:

    Abstract:Objective:To observe the curative effect of modified Buyang Huanwu Decoction combined with brain-limb coordinated regulation on post-stroke limb dysfunction. Methods: A total of 96 cases of patients with post-stroke limb dysfunction were selected as the study subjects and divided into the control group and the observation group according to the random number table method, with 48 cases in each group. The control group was treated with routine treatment and brain-limb coordinated regulation, and the observation group was additionally treated with modified Buyang Huanwu Decoction based on the treatment of the control group. Clinical effects were compared between the two groups. Changes in traditional Chinese medicine (TCM) syndrome scores , serum indicators [C-reactive protein (CRP) and homocysteine (Hcy)], hemorheological indicators [fibrinogen (Fib), plasma viscosity, and hematocrit (HCT)], and scores of Fugl-Meyer Motor Function (FMA), Berg Balance Scale (BBS), and Functional Ambulation Categories (FAC) were compared between the two groups before and after treatment. Results: After 4 weeks of treatment, the total clinical effective rate was 95.83% in the observation group and 83.33% in the control group, the difference being significant (P<0.05). After treatment, each TCM syndrome score in the two groups was decreased when compared with that before treatment (P<0.05), and each TCM syndrome score in the observation group was lower than that in the control group (P<0.05). After treatment, CRP and Hcy in the two groups were decreased when compared with those before treatment (P<0.05), and the above two indicators in the observation group were lower than those in the control group (P<0.05). After 4 weeks of treatment, Fib, plasma viscosity, and HCT in the two groups were decreased when compared with those before treatment (P<0.05),and the above three indicators in the observation group were lower than those in the control group (P<0.05). After 4 weeks of treatment, the scores of FMA,BBS,and FAC in the two groups were increased when compared with those before treatment (P<0.05), and the scores of FMA, BBS, and FAC in the observation group were higher than those in the control group (P<0.05). Conclusion: Modified Buyang Huanwu Decoction combined with brain-limb coordinated regulation for post-stroke limb dysfunction can enhance clinical effects, improve symptoms of decreased muscle strength and tone, relieve inflammation, and promote the recovery of motor function of limbs.

    参考文献
    相似文献
    引证文献
引用本文

姚先丽,李坤彬,刘亚鸽,温小鹏,吴志远,焦冰.补阳还五汤加减联合脑-肢协同调控治疗卒中后肢体功能障碍临床研究[J].新中医,2024,56(7):36-41

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-04-11
  • 出版日期: